SCOTTSDALE, Ariz., Aug. 22 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc. , an over-the-counter healthcare company that develops and markets products that provide consumers with "better ways to get better(R)," will host its 2008 Annual Meeting of Stockholders at 10:00 a.m. PDT on Tuesday, August 26, 2008 at the Marriott at McDowell Mountains in Scottsdale, Arizona. The purpose of the meeting is to elect two directors to the Company's Board of Directors to serve for a three-year term, or until their successors are elected; to ratify the appointment of Mayer Hoffman McCann P.C. as the independent registered public accounting firm of Matrixx Initiatives, Inc. for the fiscal year ending March 31, 2009; and to transact such other business as may properly come before the annual meeting. Following the formal meeting there will be a brief presentation regarding the Company's performance.
You may listen to the 2008 Annual Meeting by calling (877) 591-4951 (domestic) or (719) 325-4889 (international). To listen to the Meeting and to view the accompanying slide presentation via the Internet, log onto http://www.matrixxinc.com/ and click on the Events & Presentations icon. Please note that the broadcast will be listen-only.
An audio only replay of the Meeting will be available at (888) 203-1112 (domestic) or (719) 457-0820 (international), access number 6956456 for 3 days following the call, and the web cast with slide presentation will be archived on the Company's website, http://www.matrixxinc.com/, for 30 days.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam(R) and Nasal Comfort(TM) products in the cough and cold category, and Xcid(TM) antacid in the digestive health category. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Swabs(TM); Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Extreme Congestion Relief; Zicam Sinus Relief; as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to http://www.zicam.com/. To find out more about Matrixx Initiatives, Inc. , visit our website at http://www.matrixxinc.com/. For additional information, contact William Hemelt, Chief Financial Officer, 602-385-8888, or Bill Barba, Treasurer, at 602-385-8881. Matrixx is located at 8515 E. Anderson Dr., Scottsdale, Arizona 85255.
